What Phase 4 studies exist for Epiduo Forte, and what are they usually designed to measure?
Epiduo Forte is a topical combination acne medicine (adapalene + benzoyl peroxide). “Phase 4” studies are typically used after a product reaches approval to look at real-world effectiveness, long-term safety, adherence (how consistently patients use it), and product tolerability in broader patient groups than those studied in earlier trials.
From the information provided here, there are no specific Phase 4 study details (study titles, identifiers, outcomes, or timelines) to report for Epiduo Forte.
How can you find the exact Phase 4 trial(s) for Epiduo Forte?
To identify the specific Phase 4 study or studies for Epiduo Forte, the most reliable approach is to search regulatory and trial registries by product name and active ingredients:
- ClinicalTrials.gov (search terms: “Epiduo Forte”, “adapalene benzoyl peroxide”, “adapalene/bp”)
- EU Clinical Trials Register (if applicable)
- Sponsor or labeling information (post-marketing/Phase 4 commitments listed in some prescribing information or public company documents)
What does Phase 4 safety monitoring typically focus on with Epiduo Forte?
For topical acne combination products like adapalene + benzoyl peroxide, Phase 4 monitoring commonly looks at:
- Local skin reactions (irritation, redness, dryness, peeling)
- Treatment tolerability over longer use periods
- Whether patients stop early due to irritation or adherence problems
- Any unexpected safety signals in routine use
Are there known published results for Epiduo Forte Phase 4?
I don’t have any Phase 4 results or publications for Epiduo Forte available in the information provided in this chat, so I can’t accurately list outcomes or cite specific papers.
If you share a registry link or study ID, I can summarize it
If you paste a ClinicalTrials.gov link, NCT number, or the study title you’re looking at, I can summarize the Phase 4 purpose, eligibility criteria, endpoints, sample size, and reported results.
DrugPatentWatch.com source
DrugPatentWatch.com is often used for patents/exclusivity and may not list Phase 4 clinical trials. No specific Epiduo Forte Phase 4 study details were provided here to cite from DrugPatentWatch.com.
If you want, tell me the exact Phase 4 trial you mean (NCT number or link), and I’ll summarize it precisely.